[18F]MH.MZ
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]MH.MZ, covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases [Phase 4]